Abstract:Targeted delivery of nanomaterials to specific intracellular locations is essential for the development of many nanomaterials-based biological applications. Thus far the targeting performance has been limited due to various intracellular transport barriers, especially intracellular vesicle trapping. Here we report the application of permeation enhancers based on organic solvents in small percentage to enhance the intracellular targeted delivery of nanomaterials. Previously permeation enhancers based on organic solvents and ionic liquids have been used in overcoming biological transport barriers at tissue, organ, and cellular levels, but this strategy has so far rarely been examined for its potential in facilitating transport of nanometer-scale entities across intracellular barriers, particularly intracellular vesicle trapping. Using the cell nucleus as a model intracellular target and Tat peptide-conjugated quantum dots (QDs-Tat) as a model nanomaterial-based probe, we demonstrate that a small percentage (e.g. 1%) of organic solvent greatly enhances nucleus targeting specificity as well as increasing endocytosis-based cellular uptake of QDs. We combine vesicle colocalization (DiO dye staining), vesicle integrity (calcein dye release), and single-particle studies (pair-correlation function microscopy) to investigate the process of organic solvent-enhanced vesicle escape of QDs-Tat. The organic solvent based vesicle escape-enhancing approach is found to be not only very effective but minimally invasive, resulting in high vesicle escape efficiency with no significant disruption to the membrane integrity of either intracellular vesicles or cells. This approach drastically outperforms the commonly used vesicle escape-enhancing agent (i.e., chloroquine, whose enhancement effect is based on disrupting vesicle integrity) in both potency and minimal invasiveness. Finally, we apply organic solvent-based targeting enhancement to improve the intracellular delivery of the anticancer drug doxorubicin (DOX).

Nonspecific Organelle-Targeting Strategy with Core-Shell Nanoparticles of Varied Lipid Components/Ratios.

Tailorable Membrane‐Penetrating Nanoplatform for Highly Efficient Organelle‐Specific Localization

A Non-Residue Surface Modification Strategy for Active-Targeting Fluorescent Silica Nanoparticles to Cellular Organelles.

Self-Assembly of Biocompatible Core-Shell Nanocapsules with Tunable Surface Functionality by Microfluidics for Enhanced Drug Delivery

Tuning Targeted Liposome Avidity to Cells via Lipid Phase Separation

Microfluidic Self-Assembly of a Combinatorial Library of Single- and Dual-Ligand Liposomes for in Vitro and in Vivo Tumor Targeting

Potential-Independent Intracellular Drug Delivery and Mitochondrial Targeting

A Potent, Minimally Invasive and Simple Strategy of Enhancing Intracellular Targeted Delivery of Tat Peptide-Conjugated Quantum Dots: Organic Solvent-Based Permeation Enhancer.

Engineering a nanoscale liposome-in-liposome for in situ biochemical synthesis and multi-stage release

Design of charge converting lipid nanoparticles via a microfluidic coating technique

A Ph-Responsive Sequential-Disassembly Nanohybrid for Mitochondrial Targeting

Combination of Physicochemical Tropism and Affinity Moiety Targeting of Lipid Nanoparticles Enhances Organ Targeting

Polymeric coating lubricates nanocontainers to escape macrophage uptake for bioreceptor recognition

Hierarchical Targeting Strategy for Enhanced Tumor Tissue Accumulation/Retention and Cellular Internalization

Bioinspired Oil Core/Silica Shell Nanocarriers with Tunable and Multimodal Functionalities

Controllable Engineering and Functionalizing Nanoparticles with Specific Targeting Capability

Ultra-small Lipid-Polymer Hybrid Nanoparticles for Tumor-Penetrating Drug Delivery.

Microfluidic synthesis of multilayered lipid-polymer hybrid nanoparticles for the formulation of low solubility drugs

Core-Shell type lipid/rPAA-Chol polymer hybrid nanoparticles for invivo siRNA delivery

Facile scalable one-flow synthesis of ionizable cationic lipid library as precursors of nanoparticle carriers

Ph-Activated Size Reduction of Large Compound Nanoparticles for in Vivo Nucleus-Targeted Drug Delivery.